Literature DB >> 12574087

Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin.

Michaela Kozàkovà1, Simona Buralli, Carlo Palombo, Giampaolo Bernini, Angelica Moretti, Stefania Favilla, Stefano Taddei, Antonio Salvetti.   

Abstract

A disproportionate accumulation of fibrillar collagen is a characteristic feature of hypertensive heart disease, but the extent of myocardial fibrosis may differ in different models of hypertension. In experimental studies, aldosterone and endothelins emerge as important determinants of myocardial fibrosis. Changes in myocardial extracellular matrix and collagen deposition can be estimated noninvasively by analysis of the ultrasonic backscatter signal, which arises from tissue heterogeneity within the myocardium and describes myocardial texture. This study was designed to investigate the relations between myocardial integrated backscatter and circulating aldosterone and immunoreactive endothelin in human hypertension. The study population consisted of 56 subjects: 14 healthy normotensive volunteers and 42 hypertensive patients (14 with primary aldosteronism, 7 with renovascular hypertension, and 21 with essential hypertension). The patients with essential and secondary hypertension were matched for age, gender, body mass index, and blood pressure. Myocardial integrated backscatter at diastole was 19.8+/-2.0 and 20.8+/-2.9 decibels in normotensive control subjects and patients with essential hypertension and significantly higher in patients with primary aldosteronism (27.4+/-3.8 decibels, P<0.01) and renovascular hypertension (26.8+/-4.8 decibels, P<0.01). In the population as a whole, as well as in the hypertensive subpopulation, myocardial integrated backscatter was directly related to plasma aldosterone (r=0.73 and 0.71, P<0.01 for both) and immunoreactive endothelin (r=0.60 and 0.56, P<0.01 for both). The data of this study suggest that in human hypertension, circulating aldosterone and immunoreactive endothelin may induce alterations in left ventricular myocardial texture, possibly related to increased myocardial collagen content.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574087     DOI: 10.1161/01.hyp.0000052542.68896.2b

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

2.  Cardiac remodeling in patients with primary aldosteronism.

Authors:  F Galetta; G Bernini; F Franzoni; A Bacca; I Fivizzani; L Tocchini; M Bernini; P Fallahi; A Antonelli; G Santoro
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

Review 3.  Left heart morphology and function in primary aldosteronism.

Authors:  Alberto Milan; Corrado Magnino; Ambra Fabbri; Michela Chiarlo; Giulia Bruno; Isabel Losano; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

4.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

5.  Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.

Authors:  Yen-Hung Lin; Chia-Hung Chou; Xue-Ming Wu; Yi-Yao Chang; Chi-Sheng Hung; Ying-Hsien Chen; Yu-Lin Tzeng; Vin-Cent Wu; Yi-Lwun Ho; Fon-Jou Hsieh; Kwan-Dun Wu
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

6.  Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism.

Authors:  Marianne Aa Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson; Eystein S Husebye; Kristian Løvås; Terje H Larsen
Journal:  Endocr Connect       Date:  2018-02-12       Impact factor: 3.335

7.  Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis.

Authors:  Xueyi Wu; Jie Yu; Haoming Tian
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.

Authors:  Yuta Tezuka; Adina F Turcu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-26       Impact factor: 5.555

9.  Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.

Authors:  Adina F Turcu; Richard Auchus
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

10.  Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.

Authors:  Yi-Yao Chang; Che-Wei Liao; Cheng-Hsuan Tsai; Ching-Way Chen; Chien-Ting Pan; Zheng-Wei Chen; Ya-Li Chen; Lung-Chun Lin; Yi-Ru Chang; Vin-Cent Wu; Kwan-Dun Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Am Heart Assoc       Date:  2019-11-13       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.